CBT-1® in Combination With Doxorubicin in Patients With Metastatic, Unresectable Sarcomas Who Previously Progressed on Doxorubicin

NCT03002805 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: CBT-1®

Sponsor

CBA Research